Mice Model Market by Mice Type (Inbred, Knockout), Technology (CRISPR, TALEN, ZFN), Application (Oncology, Diabetes, Immunology), Service (Breeding, Cryopreservation, Genetic testing), Care Products (Cages, Bedding, Feed), Region - Global Forecasts to 2025
Updated on : February 17, 2023
The global mice model market in terms of revenue was estimated to be worth $1.4 billion in 2020 and is poised to reach $1.9 billion by 2025, growing at a CAGR of 6.4% from 2020 to 2025. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, increasing implications of mouse clinical trials (MCTs) for more predictive outcomes, and ongoing innovations in mice models are driving the growth of the global mice model industry.
To know about the assumptions considered for the study, Request for Free Sample Report
Mice Model Market Growth Dynamics
Drivers: Growing usage of mice models in virology and infectious diseases
Over the years, there has been an increase in the incidence of viral infectious diseases. In the past two decades, coronavirus outbreaks have taken place three times—SARS-CoV in 2002, MERS-CoV in 2012, and SARS-CoV-2 in 2019. However, the current SARS-CoV-2 is much more severe than the SARS-CoV in 2002 and has spread to more than 213 countries affecting millions of individuals. The emergence of the novel coronavirus disease in 2019 (COVID-19) has prompted the use of animal models for the study of its pathology and the development of effective treatment
Apart from coronavirus studies, mice models are considered to be the best small animal models for hepatitis B virus (HBV), hepatitis C virus (HCV), Zika virus, and cytomegalovirus (CMV), among others. According to the WHO, infectious diseases kill more than 17 million people every year. In the last two decades, over 30 new infectious diseases have emerged. According to UNAIDS, by the end of 2019, 38 million individuals were affected by HIV. Mice models have been used widely for several different viral investigations due to their small size, low cost, easy operation, and high reproducibility.
Restraints: Regulations and laws for the ethical use of animals in research
Implementation of laws and regulations for animal protection and welfare has enforced restrictive practices and bans on the use of animals for different purposes. In the last five years, many countries have banned the use of animals in the cosmetic industry. In 2018, Sri Lanka introduced a general animal welfare bill, and The Brazilian State of Minas Gerais banned cosmetic animal testing. In 2019, Australia banned the use of newly derived animal test data for cosmetics.
Institutes funded by the National Institutes of Health (NIH) are required to adhere to Public Health Service (PHS) policy and follow the Guide for the Care and Use of Laboratory Animals developed by the Institute for Laboratory Animal Research (ILAR). To increase the chances of funding, research institutes seek accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), a privately funded membership-based organization. Complying with mandatory regulations for the use of animal models is sometimes cumbersome and time-consuming and might hinder growth in the usage of animal models.
Opportunity: Rising demand for humanized mice models
Humanized mice models are important tools for conducting preclinical research to gain insights into human biology. These models are developed through the engraftment of human cells or tissues, leading to the expression of human proteins in mice.
Humanized mice are increasingly being used as models for biomedical research applications, such as cancer, infectious diseases, HIV/AIDS, regenerative medicine, and hepatitis. In March 2019, the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the US Department of Health and Human Services, announced funding for projects to conduct detailed characterization, direct comparisons, and further development of humanized immune system (HIS) mouse models. The need to identify the actual effects of drugs on humans, as well as the growing focus on studying human-specific infections, therapies, and immune responses, is promoting the development and use of humanized mice models.
By mice type, inbred mice accounted for the largest share in the mice model market
Based on drug type, the market is segmented into inbred mice, outbred mice, conditioned/surgically modified mice, hybrid/congenic mice, genetically engineered mice, and spontaneous mutant mice. In 2019, inbred mice accounted for the largest market share due to increasing applications of inbred mice in cardiovascular and immunology studies and the production of monoclonal antibodies, among others.
By service type, the breeding segment accounted for the largest share of the mice model market
Based on services, the market is segmented into breeding, quarantine, cryopreservation, rederivation, genetic testing, model in-licensing, and other services (surgical, line rescue, and in vivo pharmacology services). Breeding segmented is expected to account for the largest market share in 2020, with the highest growth rate as well. This can primarily be attributed to the increasing demand for mice models for drug discovery and development and the subsequent increase in the demand for personalized medicines.
By application, the oncology studies segment accounted for the largest share of the mice model market
Based on application, the market has been segmented into oncology studies, immunology and inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system studies (CNS), genetic studies, infectious disease studies, and other disease studies. The endocrine disease studies is further segmented into diabetes and other endocrine metabolic disease. The oncology segment is expected to account for the largest market share, with the highest growth rate as well. This can primarily be attributed to the increasing number of patients who have cancer and the subsequent increase in the demand for cancer therapies.
By Technology Type, CRISPR/Cas9 accounted for the largest share of the mice model market
Based on the type of technology used to create transgenic mice, the global market is categorized into the CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies (includes virus/vector-mediated gene transfer, and TALENs & ZFNs) segments. CRISPR is the most widely used technology in the global market and contributed to the largest share. Ease of design, high efficiency, and relatively lower cost have increased the demand for CRISPR-customized mice models.
By mice care product, cages segment accounted for the largest share of the mice model market
Based on mice care products, the market has been segmented into cages, feed, bedding, and other products (gnotobiotic equipment, water systems, and accessories). The cages segment accounted for the largest share of the global market. This can be attributed to the availability of a wide range of cages designed for specific research needs and the higher cost of cages compared to other care products.
North America accounted for the largest share of the mice model market
Based on the region, the global market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. North America accounted for the largest share of the global market. The large share of the North America region can be attributed to the presence of major players operating in this market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.
To know about the assumptions considered for the study, download the pdf brochure
Some of the key players include Charles River Laboratories (US) The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (US), JANVIER LABS (France), genOway (France), PolyGene (Switzerland), Crown Biosciences (US), TransCure Bioservices (France), Ingenious Targeting Laboratory (US), Cyagen Biosciences (US), GVK BIO (India), The Andersons, Inc. (US), Innovive (US), Allentown, LLC (US), FENGSHI Group (China), Ozgene Pty Ltd. (Australia), Harbour Biomed (US) among others.
Mice Model Market Report Scope:
|
Report Metric |
Details |
|
Market Size Available for Years |
2018–2025 |
|
Base Year Considered |
2019 |
|
Forecast Period |
2020–2025 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
Mice Type, Service, Application, Technology, Mice Care Product and Region |
|
Geographies Covered |
North America, Europe, APAC and the RoW |
|
Companies Covered |
The major market players include Charles River Laboratories, (US) The Jackson Laboratory (US), Taconic Biosciences, Inc. (US), Envigo (US), JANVIER LABS (France), genOway (France), PolyGene (Switzerland), Crown Biosciences (US), TransCure bioservices (France), Ingenious Targeting Laboratory (US), Cyagen Biosciences (US), GVK BIO (India), The Andersons, Inc. (US), Innovive (US), Allentown, LLC (US), FENGSHI Group (China), Ozgene Pty Ltd. (Australia), and Harbour Biomed (US) |
The study categorizes the mice model market into the following segments and sub-segments:
By Mice Type
- Inbred Mice
- Genetically Engineered Mice
- Outbred Mice
- Hybrid/Congenic Mice
- Conditioned/Surgically Modified Mice
- Spontaneous Mutant Mice
By Service
- Breeding
- Cryopreservation
- Quarantine
- Rederivation
- Model-in licensing
- Genetic Testing
- Other Services
By Application
- Oncology Studies
- Immunology and Inflammation Studies
-
Endocrine Metabolic Studies
- Diabetes
- Cardiovascular Studies
- Central Nervous System (CNS) Studies
- Genetic Studies
- Infectious Disease Studies
- Other Disease Studies
By Technology
- CRISPR/CAS9
- Microinjection
- Embryonic Stem cell Injection
- Nuclear Transfer
- Other Technologies
By Mice Care Product
- Cages
- Feed
- Bedding
- Other Care Products
Company Type
- Tier 1 Pharmaceutical Companies
- Tier 2 Pharmaceutical Companies
- Tier 3 Pharmaceutical Companies
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Rest of Europe
-
Asia Pacific
- Japan
- China
- South Korea
- India
- Rest of Asia Pacific
-
Rest of the World
- Latin America
- The Middle East and Africa
Recent Developments
- In 2020, GenOway acquired exclusive worldwide rights from Merck for its foundational CRISPR/Cas9 portfolio in the rodent field.
- In 2020, Taconic entered into an agreement with the University of Texas Medical Branch to distribute humanized ACE2 mice for COVID-19 research.
- In 2020, The Jackson Laboratory started the production of ACE2 mice to support the research on COVID-19.
- In 2020, Oragenics Inc. and Aragen Bioscience entered into an agreement to accelerate the development of TerraCoV2, a SARS-CoV-2 (COVID-19) vaccine candidate.
- In 2020, Innovive announced the expansion of its manufacturing facility into North Sioux City, South Dakota (US).
Frequently Asked Questions (FAQ):
What are the growth opportunities in the mice model market across major regions in the future?
Increasing demand for personalized medicines and ongoing innovations in mice models provides growth opportunities to mice model market
Emerging countries have immense opportunities for the growth and adoption of the mice model market. Will this scenario continue during the next five years?
Emerging markets also provide room for innovation. China, in particular, has a large infrastructure, with substantial government and private funding in the country’s pharmaceutical and biotechnology industry. This has resulted in many large pharmaceutical and biotechnology companies establishing state-of-the-art research facilities in China to drive the next breakthrough drug discoveries in conjunction with other Asian countries such as India
Which type of mice has the largest share in the overall market?
In 2019, the inbred mice segment accounted for the largest share of the mice model market.
By service, which is the largest share in the mice model market?
Based on service, the mice model market is segmented into breeding, quarantine, cryopreservation, rederivation, genetic testing, model in-licensing, and other services. In 2019, the breeding segment accounted for the largest share of the mice model market.
Which application holds the largest market share in the mice model market?
On the basis of application, the mice model market is segmented into oncology studies, immunology and inflammation studies, endocrine metabolic studies, cardiovascular studies, central nervous system studies (CNS), genetic studies, infectious disease studies, and other disease studies. In 2019, the oncology segment accounted for the largest share of the market.
Which mice care product has the largest market share in the overall market?
In 2019, the cages segment accounted for the largest share of the mice model market. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 40)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 45)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 1 BREAKDOWN OF PRIMARIES: MICE MODEL MARKET
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION
2.1.3.1 Data triangulation
FIGURE 2 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
FIGURE 4 GLOBAL MARKET SIZE (USD MILLION)
FIGURE 5 GLOBAL MARKET: GROWTH RATE OF TOP COMPANIES (2018−2019)
FIGURE 6 GLOBAL MARKET: FINAL CAGR PROJECTIONS (2020−2025)
FIGURE 7 GLOBAL MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES
2.3 INDUSTRY INSIGHTS
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY (Page No. - 52)
FIGURE 8 MICE MODEL MARKET SHARE, BY MICE TYPE, 2019
FIGURE 9 GLOBAL MARKET SHARE, BY SERVICE, 2019
FIGURE 10 GLOBAL MARKET, BY APPLICATION: MARKET RANKING OF SEGMENTS, BY MARKET SIZE
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 56)
4.1 MICE MODEL MARKET OVERVIEW
FIGURE 12 GROWTH IN NUMBER OF PHARMACEUTICAL R&D ACTIVITIES AND GROWING DEMAND FOR PERSONALIZED MEDICINE WILL FAVOR MARKET GROWTH
4.2 ASIA PACIFIC: MARKET SHARE, BY MICE CARE PRODUCT AND BY COUNTRY (2019)
FIGURE 13 THE CAGES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019 57
4.3 GLOBAL MARKET, BY MICE TYPE
FIGURE 14 INBRED MICE SEGMENT WILL CONTINUE TO DOMINATE THE MARKET
4.4 GLOBAL MARKET SHARE, BY SERVICE, 2020 VS. 2025
FIGURE 15 IN TERMS OF SERVICE, BREEDING HOLDS THE LARGEST SHARE OF THE MARKET 58
4.5 GLOBAL MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 16 ONCOLOGY STUDIES SEGMENT ACCOUNTS FOR THE LARGEST MARKET SHARE
5 MARKET OVERVIEW (Page No. - 60)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 17 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Growing usage of mice models in virology and infectious diseases
5.2.1.2 Increasing implications of mouse clinical trials (MCTs) for more predictive outcomes
5.2.1.3 Increasing demand for personalized medicine
5.2.2 RESTRAINTS
5.2.2.1 Regulations and laws for the ethical use of animals in research
5.2.3 OPPORTUNITIES
5.2.3.1 CRISPR emerging as a powerful tool in biomedical research
5.2.3.2 Rising demand for humanized mice models
5.2.4 CHALLENGES
5.2.4.1 Development of alternative animal testing methods
5.2.5 THREATS
5.2.5.1 Growing use of rat models
5.3 IMPACT OF THE COVID-19 OUTBREAK ON THE GROWTH OF THE GLOBAL MARKET
6 REGULATORY ASSESSMENT (Page No. - 65)
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.3 EUROPE
6.4 CHINA
6.5 JAPAN
6.6 INDIA
6.7 AUSTRALIA
6.8 BRAZIL
7 CLINICAL STUDIES ASSESSMENT (Page No. - 70)
7.1 INTRODUCTION
7.2 CLINICAL STUDIES
FIGURE 18 CLINICAL STUDIES USING MICE MODELS, BY INDICATION (2017 ONWARDS)
FIGURE 19 CLINICAL STUDIES USING MICE MODELS, BY COMPLETION (2017 ONWARDS)
TABLE 1 INDICATIVE LIST OF CLINICAL STUDIES CONDUCTED USING MICE MODELS
8 MICE MODEL MARKET, BY MICE TYPE (Page No. - 72)
8.1 INTRODUCTION
TABLE 2 GLOBAL MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
8.2 INBRED MICE MODEL MARKET
8.2.1 INCREASING APPLICATIONS OF INBRED MICE LIKELY TO DRIVE THE MARKET
TABLE 3 INBRED MICE-MODEL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 4 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 5 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
8.3 OUTBRED MICE MODEL MARKET
8.3.1 GENETIC DIVERSITY OFFERED BY OUTBRED MICE TO BOOST THE MARKET
TABLE 8 OUTBRED MICE-MODEL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 9 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
8.4 GENETICALLY ENGINEERED MICE MODEL MARKET
8.4.1 INCREASING FOCUS ON PERSONALIZED MEDICINES TO DRIVE DEMAND
TABLE 13 GENETICALLY ENGINEERED MICE-MODEL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 14 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
8.5 HYBRID/CONGENIC MICE MODEL MARKET
8.5.1 INCREASING USE OF CONGENIC MICE IN BIOMEDICAL RESEARCH CONTRIBUTES TO MARKET GROWTH
TABLE 18 HYBRID/CONGENIC MICE-MODEL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 19 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 21 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
8.6 CONDITIONED/SURGICALLY MODIFIED MICE MODEL MARKET
8.6.1 INCREASING INCIDENCE OF METABOLIC DISEASES TO DRIVE THE MARKET
TABLE 23 CONDITIONED/SURGICALLY MODIFIED MICE-MODEL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 27 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
8.7 SPONTANEOUS MUTANT MICE MODEL MARKET
8.7.1 ADVANCEMENTS IN BIOMEDICAL RESEARCH AND INCREASING APPLICATIONS TO BOOST DEMAND
TABLE 28 SPONTANEOUS MUTANT MICE-MODEL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
9 MICE MODEL MARKET, BY SERVICE (Page No. - 86)
9.1 INTRODUCTION
TABLE 33 MICE MODEL MARKET, BY SERVICE, 2018–2025 (USD MILLION)
9.2 BREEDING
9.2.1 GROWING NUMBER OF MICE MODEL STUDIES TO BOOST THE MARKET
TABLE 34 BREEDING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: BREEDING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 36 EUROPE: BREEDING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 ASIA PACIFIC: BREEDING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 38 ROW: BREEDING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
9.3 CRYOPRESERVATION
9.3.1 NEED FOR PRESERVATION OF NOVEL MICE MODELS LIKELY TO DRIVE THE MARKET
TABLE 39 CRYOPRESERVATION SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 41 EUROPE: CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 42 ASIA PACIFIC: CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 ROW: CRYOPRESERVATION SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
9.4 QUARANTINE
9.4.1 RISING DEMAND FOR GERM-FREE MICE TO BOOST MARKET
TABLE 44 QUARANTINE SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 45 NORTH AMERICA: QUARANTINE SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 46 EUROPE: QUARANTINE SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 47 ASIA PACIFIC: QUARANTINE SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 48 ROW: QUARANTINE SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
9.5 REDERIVATION
9.5.1 STRINGENT QUALITY ASSURANCE STANDARDS TO BOOST THE MARKET
TABLE 49 REDERIVATION SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 50 NORTH AMERICA: REDERIVATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 51 EUROPE: REDERIVATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 ASIA PACIFIC: REDERIVATION SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 53 ROW: REDERIVATION SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
9.6 MODEL IN-LICENSING
9.6.1 INCREASING INDEPENDENT RESEARCH BY SCIENTIFIC COMMUNITY LIKELY TO FUEL MARKET GROWTH
TABLE 54 MODEL IN-LICENSING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 55 NORTH AMERICA: MODEL IN-LICENSING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 56 EUROPE: MODEL IN-LICENSING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 57 ASIA PACIFIC: MODEL IN-LICENSING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 58 ROW: MODEL IN-LICENSING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
9.7 GENETIC TESTING
9.7.1 RISING DEMAND FOR TRANSGENIC MICE LIKELY TO DRIVE THE MARKET
TABLE 59 GENETIC TESTING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 60 NORTH AMERICA: GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 61 EUROPE: GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 62 ASIA PACIFIC: GENETIC TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 63 ROW: GENETIC TESTING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
9.8 OTHER SERVICES
TABLE 64 OTHER SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 65 NORTH AMERICA: OTHER SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 66 EUROPE: OTHER SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 67 ASIA PACIFIC: OTHER SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 68 ROW: OTHER SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
10 MICE MODEL MARKET, BY TECHNOLOGY (Page No. - 102)
10.1 INTRODUCTION
TABLE 69 GLOBAL MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 70 GLOBAL MARKET, BY OTHER TECHNOLOGIES, 2018–2025 (USD MILLION)
10.2 CRISPR/CAS9
10.2.1 ADVANTAGES OF CRISPR LIKELY TO BOOST SEGMENT GROWTH
TABLE 71 GLOBAL MARKET SIZE FOR CRISPR TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
TABLE 72 NORTH AMERICA: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 73 EUROPE: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 74 ASIA PACIFIC: CRISPR TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 75 ROW: CRISPR TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
10.3 MICROINJECTION
10.3.1 HIGH SUCCESS RATE AND LACK OF CONSTRAINTS TO PROPEL SEGMENT
TABLE 76 GLOBAL MARKET SIZE FOR MICROINJECTION TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
TABLE 77 NORTH AMERICA: MICROINJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 78 EUROPE: MICROINJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 79 ASIA PACIFIC: MICROINJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 80 ROW: MICROINJECTION TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
10.4 EMBRYONIC STEM CELL INJECTION
10.4.1 GROWING DEMAND FOR TARGETED MICE MODELS TO PROPEL THE MARKET
TABLE 81 GLOBAL MARKET SIZE FOR EMBRYONIC STEM CELL INJECTION TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
TABLE 82 NORTH AMERICA: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 83 EUROPE: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 84 ASIA PACIFIC: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 85 ROW: EMBRYONIC STEM CELL INJECTION TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
10.5 NUCLEAR TRANSFER
10.5.1 POTENTIAL TO PRODUCE IDENTICAL MICE IS LIKELY TO DRIVE MARKET GROWTH
TABLE 86 GLOBAL MARKET SIZE FOR NUCLEAR TRANSFER TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
TABLE 87 NORTH AMERICA: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 88 EUROPE: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 89 ASIA PACIFIC: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 90 ROW: NUCLEAR TRANSFER TECHNOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
10.6 OTHER TECHNOLOGIES
TABLE 91 GLOBAL MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 92 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 93 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 94 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 95 ROW: OTHER TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION)
10.6.1 SPERM-MEDIATED GENE TRANSFER
TABLE 96 GLOBAL MARKET SIZE FOR SPERM-MEDIATED GENE TRANSFER TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
10.6.2 VIRUS/VECTOR-MEDIATED GENE TRANSFER
TABLE 97 GLOBAL MARKET SIZE FOR VIRUS/VECTOR-MEDIATED GENE TRANSFER TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
10.6.3 LIPOSOME-MEDIATED DNA AND ELECTROPORATION OF DNA
TABLE 98 GLOBAL MARKET SIZE FOR LIPOSOME-MEDIATED DNA AND ELECTROPORATION OF DNA TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
10.6.4 BIOLISTICS
TABLE 99 GLOBAL MARKET SIZE FOR BIOLISTICS TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
10.6.5 TALENS AND ZFNS
TABLE 100 GLOBAL MARKET SIZE FOR TALENS AND ZFNS TECHNOLOGY, BY REGION, 2018–2025 (USD MILLION)
11 MICE MODEL MARKET, BY APPLICATION (Page No. - 117)
11.1 INTRODUCTION
TABLE 101 GLOBAL MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 102 GLOBAL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
11.2 ONCOLOGY STUDIES
11.2.1 INCREASING IMPLICATIONS OF MICE MODELS IN STUDY OF CANCER TO DRIVE THE MARKET
TABLE 103 GLOBAL MARKET SIZE FOR ONCOLOGY STUDIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 104 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 105 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 106 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 107 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
11.3 IMMUNOLOGY AND INFLAMMATION STUDIES
11.3.1 DEVELOPMENT OF ADVANCED MODELS FOR HUMAN IMMUNOLOGY STUDIES TO BOOST MARKET GROWTH
TABLE 108 GLOBAL MARKET SIZE FOR IMMUNOLOGY AND INFLAMMATION STUDIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 109 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 110 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 111 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 112 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
11.4 ENDOCRINE METABOLIC STUDIES
11.4.1 GROWING PREVALENCE OF METABOLIC DISORDERS LIKELY TO DRIVE THE MARKET
TABLE 113 GLOBAL MARKET SIZE FOR ENDOCRINE METABOLIC STUDIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 114 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 115 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 116 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 117 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
11.4.2 DIABETES STUDIES
TABLE 118 GLOBAL MARKET SIZE FOR DIABETES STUDIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 119 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 120 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 121 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 122 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
11.4.3 OTHER ENDOCRINE METABOLIC STUDIES
TABLE 123 GLOBAL MARKET SIZE FOR OTHER ENDOCRINE METABOLIC STUDIES, BY REGION, 2018–2025 (USD MILLION)
11.5 CARDIOVASCULAR STUDIES
11.5.1 RISING BURDEN OF CARDIOVASCULAR DISORDERS HAS BOOSTED OVERALL R&D ACTIVITY
TABLE 124 GLOBAL MARKET SIZE FOR CARDIOVASCULAR STUDIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 125 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 126 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 127 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 128 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
11.6 CENTRAL NERVOUS SYSTEM (CNS) STUDIES
11.6.1 INCREASING FOCUS ON MICE MODEL DEVELOPMENT FOR CNS DISORDERS TO PROPEL MARKET
TABLE 129 GLOBAL MARKET SIZE FOR CENTRAL NERVOUS SYSTEM STUDIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 130 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 131 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 132 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 133 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
11.7 GENETIC STUDIES
11.7.1 ADVANCEMENTS IN GENE EDITING TECHNIQUES TO DRIVE THE MARKET
TABLE 134 GLOBAL MARKET SIZE FOR GENETIC STUDIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 135 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 136 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 137 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 138 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
11.8 INFECTIOUS DISEASE STUDIES
11.8.1 INCREASING OUTBREAKS OF INFECTIOUS DISEASES TO PROPEL DRUG DEVELOPMENT ACTIVITIES
TABLE 139 GLOBAL MARKET SIZE FOR INFECTIOUS DISEASE STUDIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 140 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 141 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 142 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 143 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
11.9 OTHER DISEASE STUDIES
TABLE 144 GLOBAL MARKET SIZE FOR OTHER DISEASE STUDIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 145 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 146 EUROPE: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 147 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 148 ROW: MARKET, BY REGION, 2018–2025 (USD MILLION)
12 MICE MODEL MARKET, BY MICE CARE PRODUCT (Page No. - 138)
12.1 INTRODUCTION
TABLE 149 MICE CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
12.2 CAGES
12.2.1 DEVELOPMENT OF DIFFERENT CAGE SYSTEMS TO DRIVE THE MARKET
TABLE 150 MICE CAGES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 151 NORTH AMERICA: MICE CAGES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 152 EUROPE: MICE CAGES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 153 ASIA PACIFIC: MICE CAGES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 154 ROW: MICE CAGES MARKET, BY REGION, 2018–2025 (USD MILLION)
12.3 FEED
12.3.1 PREFERENCE FOR HEALTHY AND POWERED DIET TO DRIVE THE MARKET
TABLE 155 MICE FEED MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 156 NORTH AMERICA: MICE FEED MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 157 EUROPE: MICE FEED MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 158 ASIA PACIFIC: MICE FEED MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 159 ROW: MICE FEED MARKET, BY REGION, 2018–2025 (USD MILLION)
12.4 BEDDING
12.4.1 ENVIRONMENTAL ENRICHMENT STRATEGY FOR WELFARE OF LABORATORY ANIMALS LIKELY TO BOOST MARKET GROWTH
TABLE 160 MICE BEDDING MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 161 NORTH AMERICA: MICE BEDDING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 162 EUROPE: MICE BEDDING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 163 ASIA PACIFIC: MICE BEDDING MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 164 ROW: MICE BEDDING MARKET, BY REGION, 2018–2025 (USD MILLION)
12.5 OTHER MICE CARE PRODUCTS
TABLE 165 OTHER MICE CARE PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 166 NORTH AMERICA: OTHER MICE CARE PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 167 EUROPE: OTHER MICE CARE PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 168 ASIA PACIFIC: OTHER MICE CARE PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 169 ROW: OTHER MICE CARE PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
13 MICE MODEL MARKET, BY REGION (Page No. - 148)
13.1 INTRODUCTION
FIGURE 20 MICE MODEL MARKET SNAPSHOT
TABLE 170 GLOBAL MARKET, BY REGION, 2018–2025 (USD MILLION)
13.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT
TABLE 171 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 172 NORTH AMERICA: MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 173 NORTH AMERICA: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 174 NORTH AMERICA: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 175 NORTH AMERICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 176 NORTH AMERICA: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 177 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 178 NORTH AMERICA: MARKET, BY OTHER TECHNOLOGIES, 2018–2025 (USD MILLION)
TABLE 179 NORTH AMERICA: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.2.1 US
13.2.1.1 Government funding for life sciences research drives market growth in the US
13.2.1.2 Rising production of monoclonal antibodies to augment use of mice models
TABLE 180 US: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 181 US: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 182 US: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 183 US: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 184 US: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 185 US: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 186 US: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.2.2 CANADA
13.2.2.1 Growth in stem cell research activities expected to lead to expansion of mice model market
TABLE 187 CANADA: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 188 CANADA: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 189 CANADA: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 190 CANADA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 191 CANADA: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 192 CANADA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 193 CANADA: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.3 EUROPE
TABLE 194 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 195 EUROPE: MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 196 EUROPE: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 197 EUROPE: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 198 EUROPE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 199 EUROPE: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 200 EUROPE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 201 EUROPE: MARKET, BY OTHER TECHNOLOGIES, 2018–2025 (USD MILLION)
TABLE 202 EUROPE: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.3.1 GERMANY
13.3.1.1 Germany accounted for the second-largest share of the European market
TABLE 203 GERMANY: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 204 GERMANY: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 205 GERMANY: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 206 GERMANY: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 207 GERMANY MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 208 GERMANY: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 209 GERMANY: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.3.2 FRANCE
13.3.2.1 Increased investments in proteomics and genomics likely to fuel growth of mice models
TABLE 210 FRANCE: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 211 FRANCE: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 212 FRANCE: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 213 FRANCE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 214 FRANCE: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 215 FRANCE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 216 FRANCE: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.3.3 UK
13.3.3.1 Increasing focus on cancer research in the UK is a key market growth driver
TABLE 217 UK: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 218 UK: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 219 UK: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 220 UK: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 221 UK: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 222 UK: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 223 UK: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.3.4 REST OF EUROPE
13.3.4.1 EU funding to support biomedical research
TABLE 224 REST OF EUROPE: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 225 REST OF EUROPE: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 226 REST OF EUROPE: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 227 REST OF EUROPE: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 228 REST OF EUROPE: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 229 REST OF EUROPE: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 230 REST OF EUROPE: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT
TABLE 231 ASIA PACIFIC: MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 232 ASIA PACIFIC: MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 233 ASIA PACIFIC: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 234 ASIA PACIFIC: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 235 ASIA PACIFIC: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 236 ASIA PACIFIC: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 237 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 238 ASIA PACIFIC: MARKET, BY OTHER TECHNOLOGIES, 2018–2025 (USD MILLION)
TABLE 239 ASIA PACIFIC: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.4.1 JAPAN
13.4.1.1 Increasing focus on personalized diagnostics products to support market growth
TABLE 240 JAPAN: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 241 JAPAN: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 242 JAPAN: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 243 JAPAN: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 244 JAPAN: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 245 JAPAN: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 246 JAPAN: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.4.2 CHINA
13.4.2.1 International alliances for R&D activities are driving the market
TABLE 247 CHINA: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 248 CHINA: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 249 CHINA: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 250 CHINA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 251 CHINA: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 252 CHINA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 253 CHINA: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.4.3 INDIA
13.4.3.1 Robust growth in biotech industry in India to boost the mice model market
TABLE 254 INDIA: MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 255 INDIA: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 256 INDIA: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 257 INDIA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 258 INDIA: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 259 INDIA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 260 INDIA: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.4.4 SOUTH KOREA
13.4.4.1 Resolute R&D investment in drug development
TABLE 261 SOUTH KOREA: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 262 SOUTH KOREA: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 263 SOUTH KOREA: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 264 SOUTH KOREA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 265 SOUTH KOREA: MODEL MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 266 SOUTH KOREA: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 267 SOUTH KOREA: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.4.5 REST OF ASIA PACIFIC
13.4.5.1 Increase in animal research to boost the mice model market
TABLE 268 R0APAC: MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 269 R0APAC: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 270 R0APAC: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 271 R0APAC: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 272 R0APAC: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 273 R0APAC: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 274 R0APAC: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.5 REST OF THE WORLD
TABLE 275 ROW: MICE MODEL MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 276 ROW: MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 277 ROW: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 278 ROW: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 279 ROW: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 280 ROW: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 281 ROW: MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)
TABLE 282 ROW: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.5.1 LATIN AMERICA
13.5.1.1 The growing pharmaceutical industry will propel drug development in Latin America
TABLE 283 LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 284 LATIN AMERICA: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 285 LATIN AMERICA: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 286 LATIN AMERICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 287 LATIN AMERICA: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 288 LATIN AMERICA: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
13.5.2 MIDDLE EAST & AFRICA
13.5.2.1 Infrastructural development expected to contribute to the growth of the regional market
TABLE 289 MIDDLE EAST & AFRICA: MICE MODEL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 290 MIDDLE EAST & AFRICA: MARKET, BY SERVICE, 2018–2025 (USD MILLION)
TABLE 291 MIDDLE EAST & AFRICA: MARKET, BY MICE TYPE, 2018–2025 (USD MILLION)
TABLE 292 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 293 MIDDLE EAST & AFRICA: MARKET, BY ENDOCRINE METABOLIC STUDIES, 2018–2025 (USD MILLION)
TABLE 294 MIDDLE EAST & AFRICA: MARKET, BY MICE CARE PRODUCT, 2018–2025 (USD MILLION)
14 COMPETITIVE LANDSCAPE (Page No. - 207)
14.1 INTRODUCTION
14.2 MARKET RANKING ANALYSIS
FIGURE 23 COMPANY RANKING IN THE MICE MODEL MARKET, 2019
15 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 209)
15.1 OVERVIEW
15.2 GLOBAL MARKET: COMPANY EVALUATION MATRIX
15.2.1 STARS
15.2.2 EMERGING LEADERS
15.2.3 PERVASIVE COMPANIES
15.2.4 PARTICIPANTS
FIGURE 24 GLOBAL MARKET: COMPANY EVALUATION MATRIX, 2019
15.3 MARKET EVALUATION FRAMEWORK
TABLE 295 MARKET EVALUATION FRAMEWORK: PRODUCT DEVELOPMENT & LAUNCH IS THE MAJOR STRATEGY ADOPTED BY PLAYERS
15.4 COMPETITIVE SCENARIO
15.4.1 KEY PRODUCT LAUNCHES
15.4.2 KEY ACQUISITIONS
15.4.3 KEY COLLABORATIONS
15.4.4 KEY SERVICE EXPANSIONS
15.5 COMPANY PROFILES
(Business overview, Products offered, Recent developments, MNM view)*
15.5.1 CHARLES RIVER LABORATORIES INTERNATIONAL
FIGURE 25 CHARLES RIVER LABORATORIES INTERNATIONAL: COMPANY SNAPSHOT (2019)
15.5.2 THE JACKSON LABORATORY
FIGURE 26 THE JACKSON LABORATORY: COMPANY SNAPSHOT (2019)
15.5.3 ENVIGO
15.5.4 GENOWAY
FIGURE 27 GENOWAY: COMPANY SNAPSHOT (2019)
15.5.5 TACONIC BIOSCIENCES, INC.
15.5.6 JANVIER LABS
15.5.7 HARBOUR BIOMED
15.5.8 TRANS GENIC, INC.
FIGURE 28 TRANS GENIC, INC.: COMPANY SNAPSHOT (2019)
15.5.9 INGENIOUS TARGETING LABORATORY
15.5.10 POLYGENE
15.5.11 GVK BIO
15.5.12 CYAGEN BIOSCIENCES
15.5.13 CROWN BIOSCIENCE INC. (A SUBSIDIARY OF JSR CORPORATION)
15.5.14 TRANSCURE BIOSERVICES
15.5.15 OZGENE PTY LTD
15.5.16 THE ANDERSONS, INC.
FIGURE 29 THE ANDERSONS, INC.: COMPANY SNAPSHOT (2019)
15.5.17 FENGSHI GROUP
15.5.18 ALLENTOWN, LLC
15.5.19 INNOVIVE
15.5.20 LAB PRODUCTS, INC
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
16 APPENDIX (Page No. - 257)
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 AVAILABLE CUSTOMIZATIONS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and assess market prospects. The size of the mice model market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred to for this research study include publications from the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the US Food and Drug Administration (FDA), the Netherlands Cancer Institute (NKI), the UK Medical Research Council (MRC), the European Medicines Agency (EMA), the International Mouse Phenotyping Consortium (IMPC), the Association of Assessment and Accreditation of Laboratory Animal Care (AAALAC) International, and the American Association for Laboratory Animal Science (AALAS). Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global mice model market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mice model market scenario through secondary research. Several primary interviews were conducted with market experts from both, the demand side (such as personnel from the pharmaceutical and biopharmaceutical industries) and the supply side (such as C-level and D-level executives, business heads, marketing and sales managers of key manufacturers, and distributors) across four major regions—North America, Europe, the Asia Pacific, and the Rest of the World. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by mice type, services, mice care products, application, technology company type, and region).
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Report Objectives
- To define, describe, and measure the global mice model market based on mice type, technology, application, service, mice care product, and region
- To provide detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the growth of the market
- To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the global mice model market
- To analyze the opportunities in the global mice model market for key stakeholders and provide details of the competitive landscape for major market leaders
- To forecast the size of the market segments with respect to four main regions: North America, Europe, Asia Pacific, and Rest of the World (RoW)
- To profile the key players and comprehensively analyze their core competencies2 in terms of key developments, product portfolios, and financials
- To track and analyze competitive developments such as partnerships, agreements, alliances, joint ventures, collaborations, product launches, expansions, acquisitions, grants/funds, and licensing agreements, among others, in the mice model market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the client’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Further Split Of The Mice Model Market For Latam
- Mice model market size and growth rate estimates for Brazil, Mexico, and Argentina
Growth opportunities and latent adjacency in Mice Model Market